N4A

4,4'-[{3-[(naphthalen-2-ylsulfonyl)amino]pyridine-2,6-diyl}bis(oxy)]dibenzenecarboximidamide

Created:	2013-09-09
Last modified:	2014-03-19

Find Related PDB Entry
1 entries where N4A is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	64
Chiral Atom Count	0
Bond Count	68
Aromatic Bond Count	29

2D diagram of N4A

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	4,4'-[{3-[(naphthalen-2-ylsulfonyl)amino]pyridine-2,6-diyl}bis(oxy)]dibenzenecarboximidamide
Systematic Name (OpenEye OEToolkits)	4-[6-(4-carbamimidoylphenoxy)-5-(naphthalen-2-ylsulfonylamino)pyridin-2-yl]oxybenzenecarboximidamide
Formula	C₂₉ H₂₄ N₆ O₄ S
Molecular Weight	552.604
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	O=S(=O)(c2cc1ccccc1cc2)Nc5ccc(Oc3ccc(C(=[N@H])N)cc3)nc5Oc4ccc(C(=[N@H])N)cc4
SMILES	CACTVS	3.385	NC(=N)c1ccc(Oc2ccc(N[S](=O)(=O)c3ccc4ccccc4c3)c(Oc5ccc(cc5)C(N)=N)n2)cc1
SMILES	OpenEye OEToolkits	1.7.6	c1ccc2cc(ccc2c1)S(=O)(=O)Nc3ccc(nc3Oc4ccc(cc4)C(=N)N)Oc5ccc(cc5)C(=N)N
Canonical SMILES	CACTVS	3.385	NC(=N)c1ccc(Oc2ccc(N[S](=O)(=O)c3ccc4ccccc4c3)c(Oc5ccc(cc5)C(N)=N)n2)cc1
Canonical SMILES	OpenEye OEToolkits	1.7.6	[H]/N=C(\c1ccc(cc1)Oc2ccc(c(n2)Oc3ccc(cc3)/C(=N\[H])/N)NS(=O)(=O)c4ccc5ccccc5c4)/N
InChI	InChI	1.03	InChI=1S/C29H24N6O4S/c30-27(31)19-5-10-22(11-6-19)38-26-16-15-25(29(34-26)39-23-12-7-20(8-13-23)28(32)33)35-40(36,37)24-14-9-18-3-1-2-4-21(18)17-24/h1-17,35H,(H3,30,31)(H3,32,33)
InChIKey	InChI	1.03	YVYNZHGMLLXWDD-UHFFFAOYSA-N

Related Resource References

Resource Name	Reference
Pharos	CHEMBL3099812
PubChem	49820500
ChEMBL	CHEMBL3099812

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.